Biomarkers for Traumatic Brain Injury (eBook, PDF)
Redaktion: Dambinova, Svetlana; Wang, Kevin K. W.; Hayes, Ronald L
126,95 €
126,95 €
inkl. MwSt.
Sofort per Download lieferbar
63 °P sammeln
126,95 €
Als Download kaufen
126,95 €
inkl. MwSt.
Sofort per Download lieferbar
63 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
126,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
63 °P sammeln
Biomarkers for Traumatic Brain Injury (eBook, PDF)
Redaktion: Dambinova, Svetlana; Wang, Kevin K. W.; Hayes, Ronald L
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
- Größe: 3.48MB
Produktdetails
- Verlag: RSC
- Seitenzahl: 246
- Erscheinungstermin: 24. Mai 2012
- Englisch
- ISBN-13: 9781849734745
- Artikelnr.: 44768208
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, D ausgeliefert werden.
Svetlana A Dambinova DSc, PhD is a Distinguished Professor at the WellStar College of Health and Human Services, Kennesaw State University, USA. She has more than 35 years of experience in the fields of molecular neurobiology, neurochemistry, and laboratory medicine. She spent most of her academic life at the Institute of Experimental Medicine, the Institute of Human Brain and Pavlov's Medical University in St Petersburg, Russia, during her career from a predoctoral student to a Professor. Ronald L Hayes PhD is Founder & President and a Distinguished Principal Investigator at the Center of Innovative Research, Banyan Biomarkers, Inc, USA. His research involves studying the pathobiology of traumatic brain injury and he employs contemporary biochemical approaches to examine proteolytic mechanisms of cell injury and death. Kevin KW Wang PhD is Founder, Chief Operations & Scientific Officer and Executive Director at the Center of Innovative Research, Banyan Biomarkers, Inc, USA.
Preface
Introduction
Medical Need of Biomarkers for TBI
The Role of Advanced MRI Findings as Biomarkers of TBI
Advances in the Measurement of Mild TBI
Neurodegradomics and Biomarkers for Concussions
Ionotropic Glutamate Receptors: Preclinical Research
Clinical Application of Early Biomarkers for Mild TBI
Astroglial Proteins as Biomarkers of Intracerebral Hemorrhage
Novel Biomarkers of Combat TBI
Utilities of TBI Biomarkers in Various Clinical Settings
Economic Impact of Biomarkers on TBI Management
TBI Biomarker Assay Development: Future Trends
Subject Index
Introduction
Medical Need of Biomarkers for TBI
The Role of Advanced MRI Findings as Biomarkers of TBI
Advances in the Measurement of Mild TBI
Neurodegradomics and Biomarkers for Concussions
Ionotropic Glutamate Receptors: Preclinical Research
Clinical Application of Early Biomarkers for Mild TBI
Astroglial Proteins as Biomarkers of Intracerebral Hemorrhage
Novel Biomarkers of Combat TBI
Utilities of TBI Biomarkers in Various Clinical Settings
Economic Impact of Biomarkers on TBI Management
TBI Biomarker Assay Development: Future Trends
Subject Index
Preface
Introduction
Medical Need of Biomarkers for TBI
The Role of Advanced MRI Findings as Biomarkers of TBI
Advances in the Measurement of Mild TBI
Neurodegradomics and Biomarkers for Concussions
Ionotropic Glutamate Receptors: Preclinical Research
Clinical Application of Early Biomarkers for Mild TBI
Astroglial Proteins as Biomarkers of Intracerebral Hemorrhage
Novel Biomarkers of Combat TBI
Utilities of TBI Biomarkers in Various Clinical Settings
Economic Impact of Biomarkers on TBI Management
TBI Biomarker Assay Development: Future Trends
Subject Index
Introduction
Medical Need of Biomarkers for TBI
The Role of Advanced MRI Findings as Biomarkers of TBI
Advances in the Measurement of Mild TBI
Neurodegradomics and Biomarkers for Concussions
Ionotropic Glutamate Receptors: Preclinical Research
Clinical Application of Early Biomarkers for Mild TBI
Astroglial Proteins as Biomarkers of Intracerebral Hemorrhage
Novel Biomarkers of Combat TBI
Utilities of TBI Biomarkers in Various Clinical Settings
Economic Impact of Biomarkers on TBI Management
TBI Biomarker Assay Development: Future Trends
Subject Index